Browsing Rapporter og andre publikasjoner fra Kunnskapssenteret by Subject "Drug Costs"
Now showing items 1-2 of 2
-
Helseøkonomisk analyse av bevacizumab+paclitaxel sammenlignet med paclitaxel alene som førstelinjebehandling ved metastatisk brystkreft
(Rapport, Peer reviewed; Research report, 2009-04)BACKGROUND The Norwegian Knowledge Centre for the Health Services has been commissioned by Norwegian Directorate of Health’s Cancer Programme to make an assessment of the cost per progression-free year gained associated ... -
Kostnader og leveårsgevinster ved medikamentell primærforebygging av hjertekarsykdom
(Rapport fra Kunnskapssenteret, Peer reviewed; Research report, 2008-12)BACKGROUND Cardiovascular disease (CVD) has for decades been the most common cause of death in Norway and most other Western countries. Several groups of drugs have shown in clinical trials to prevent CVD. In this report, ...